Aβ protofibril binding antibodies

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9573994
APP PUB NO 20160009793A1
SERIAL NO

14794172

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the amyloid beta peptide (Aβ) and more specifically to antibodies binding to Aβ protofibrils and their use in therapy and/or prophylactic treatment of Alzheimer's disease and other disorders associated with Aβ protein aggregation. Further the invention may relate to diagnosis of such diseases as well as monitoring of disease progression by use of the antibodies of the invention. Further, the invention may relate to veterinary use of the antibodies of the invention.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EISAI R&D MANAGEMENT CO LTD4-6-10 KOISHIKAWA BUNKYO-KU TOKYO 1128088 ?1128088
BIOARCTIC NEUROSCIENCE ABSTOCKHOLM SWE STOCKHOLM

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Laudon, Hanna Nacka, SE 1 2
Nerelius, Charlotte Uppsala, SE 1 2
Sigvardson, Jessica Spånga, SE 3 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 21, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00